Active, Not Recruiting
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
NCT06537414
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site San Jose, California, United States
- GSK Investigational Site Minneapolis, Minnesota, United States
- GSK Investigational Site New York, United States